A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors

NCT02605083 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
66
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated after determination of the RP2D, prior to opening expansion cohorts)

Conditions

Interventions

Sponsor

Effector Therapeutics